Please enable JavaScript in your browser to complete this form.Please enable JavaScript in your browser to complete this form. 17.00 session Name *FirstLastBreakout session DAY 1 | 16.15 - 16.45 *--- Select Choice ---Can DNA Biomarkers enhance Non-Muscle Invasive Bladder Cancer Surveillance? Evaluating the efficacy of Multimodal Genomic Profiling for bladder cancer recurrence and progression: A Prospective Longitudinal StudyRole of OncoDEEP in Resolving Histological Overlap: Exclusion of Secretory Breast Carcinoma in a Triple-Negative TumourComprehensive Genomic Profiling (OncoDEEP) identifies potential therapeutic targets and reveals novel insights into the genomic landscape of extra skeletal myxoid chondrosarcomaBreakout session DAY 1 | 17.00 - 17.30 *--- Select Choice ---One Panel, One Pipeline: Implementing OncoDEEP (and OncoSELECT) for a streamlined routine diagnosistic serviceImproving HRD detection through genomic instability signatures and pre-analytical DNA quality controlValidation of the Large OncoDEEP RNA Panel: Our experience at the Hospital Clinic of BarcelonaBreakout session DAY 2 | 10.15 - 10.45 *--- Select Choice ---Integrating Longitudinal Genomic Profiling to Navigate Clonal Evolution and Multi-Pathway Resistance in Metastatic Breast CancerValidation of an automated OncoDEEP workflow using the Hamilton StarBreakout session DAY 2 | 10.45 - 11.15 *--- Select Choice ---Insights from OncoDEEP validation on the Aviti24 platformThe experience of implementing OncoDEEP and OncoSELECT enabled by an MGI sequencerBreakout session DAY 2 | 11.15 - 11.45 *--- Select Choice ---In-house analytical validation of HRD detection in HGSOC using the OncoDEEP assay for routine diagnostic implementationNavigating Validation Challenges at OncoDNA: From Reagents and Bioinformatics to Reporting in a Rapidly Evolving Environment and working towards CE-IVDR-Validated SolutionsSubmit
